Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Cryotherapy for Prostate Cancer

  • Chapter
  • First Online:
Urological Oncology

  • 1611 Accesses

Abstract

Cryotherapy is one of the current treatment options for prostate cancer, with several inherent characteristics making it technically well suited for both primary and salvage therapy. Cryotherapy uses cold temperature (ice) to ablate malignant tissue in a specific area of interest. Multiple cryoprobes are placed into the prostate percutaneously under ultrasound guidance at strategic locations for freezing. By limiting the number of cryoprobes and adjusting their placement, it is possible to perform a focal treatment that ablates only a targeted portion of the gland. Modern cryotherapy appears to provide good cancer control while limiting morbidity and available long-term results support it as a safe and reliable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180(5):1993–2004.

    Article  PubMed  Google Scholar 

  2. Finley DS, Pouliot F, Miller DC, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010;37(1):67–82.

    Article  PubMed  Google Scholar 

  3. Robilotto AT, Clarke D, Baust JM, et al. Development of a tissue engineered human prostate tumor equivalent for use in the evaluation of cryoablative techniques. Technol Cancer Res Treat. 2007;6:81–9.

    Article  PubMed  Google Scholar 

  4. Klossner DP, Robilotto AT, Clarke DM, et al. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology. 2007;55(3):189–99.

    Article  PubMed  Google Scholar 

  5. Ellis DS, Manny Jr TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69(2):306–10.

    Article  PubMed  Google Scholar 

  6. Levy DA, Pisters LL, Jones JS. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol. 2009;182(3):931–7.

    Article  CAS  PubMed  Google Scholar 

  7. Caso JR, Tsivian M, Mouraviev V, Polascik TJ. Predicting biopsy-proven prostate cancer recurrence following cryosurgery. Urol Oncol. 2012;30(4):391–5.

    Article  PubMed  Google Scholar 

  8. Pisters LL. Cryotherapy for prostate cancer: ready for prime time? Curr Opin Urol. 2010;20(3):218–22.

    Article  PubMed  Google Scholar 

  9. Caso JR, Tsivian M, Mouraviev V, et al. Complications and postoperative events after cryosurgery for prostate cancer. BJU Int. 2012;109(6):840–5.

    Article  PubMed  Google Scholar 

  10. Cohen JK, Miller Jr RJ, Ahmed S, Lotz MJ, Baust J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71(3):515–8.

    Article  PubMed  Google Scholar 

  11. Jones JS, Rewcastle JC, Donnelly BJ, et al. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):554–8.

    Article  PubMed  Google Scholar 

  12. Cheetham P, Truesdale M, Chaudhury S, et al. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol. 2010;24(7):1123–9.

    Article  PubMed  Google Scholar 

  13. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103(8):1625–30.

    Article  PubMed  Google Scholar 

  14. Langenhuijsen JF, Broers EM, Vergunst H. Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. Eur Urol. 2009;55(1):76–86.

    Article  PubMed  Google Scholar 

  15. Spiess PE, Given RW, Jones JS. Achieving the ‘bifecta’ using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) Registry data. BJU Int. 2012;110(2):217–20.

    Article  PubMed  Google Scholar 

  16. Williams AK, Martínez CH, Lu C, et al. Disease free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol. 2011;60(3):405–10.

    Article  PubMed  Google Scholar 

  17. Gowardhan B, Greene D. Salvage cryotherapy: is there a role for focal therapy? J Endourol. 2010;24(5):861–4.

    Article  PubMed  Google Scholar 

  18. de la Rosette J, Ahmed H, Barentsz J, et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010;24(5):775–80.

    Article  PubMed  Google Scholar 

  19. Eggener SE, Scardino PT, Carroll PR, et al. International Task Force on Prostate Cancer and the Focal Lesion Paradigm. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007;178(6):2260–7.

    Google Scholar 

  20. Taneja SS, Mason M. Candidate selection for prostate cancer focal therapy. J Endourol. 2010;24(5):835–41.

    Article  PubMed  Google Scholar 

  21. Mouraviev V, Johansen TE, Polascik TJ. Contemporary results of focal therapy for prostate cancer using cryoablation. J Endourol. 2010;24(5):827–34.

    Article  PubMed  Google Scholar 

  22. Bahn DK, Silverman P, Lee Sr F, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20(9):688–92.

    Article  PubMed  Google Scholar 

  23. Onik G, Vaughan D, Lotenfoe R, et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.

    Article  PubMed  Google Scholar 

  24. Truesdale MD, Cheetham PJ, Hruby GW, et al. An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up. Cancer J. 2010;16(5):544–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Institut Montsouris- Universite Paris Descartes, Paris, France

    Eric Barret MD

Authors
  1. Eric Barret MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Barret MD .

Editor information

Editors and Affiliations

  1. Department of Urology, Homerton University Hospital & Formerly St. Bartholomew's Hospital, London, United Kingdom

    Vinod H. Nargund

  2. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA

    Derek Raghavan

  3. Radiation Oncology, Cedars Sinai Cancer Center, Los Angeles, California, USA

    Howard M. Sandler

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Barret, E. (2015). Cryotherapy for Prostate Cancer. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_44

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-482-1_44

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-481-4

  • Online ISBN: 978-0-85729-482-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation